Skip to main content

Table 2 Association between the admission 2OG levels and short-term outcomes

From: Association between admission plasma 2-oxoglutarate levels and short-term outcomes in patients with acute heart failure: a prospective cohort study

  OR (95% CI) p Per-SD increase p
Unadjusted 2.2 (1.3, 3.7) 0.003 1.4 (1.1, 1.8) 0.001
Adjusted model 1 2.1 (1.2, 3.6) 0.012 1.4 (1.1, 1.8) 0.004
Adjusted model 2 1.9 (1.1, 3.4) 0.032 1.4 (1.1, 1.7) 0.018
  1. Model 1: adjusted for age, sex, BMI, current smoking, LDL-C, AF, DM and hypertension; model 2: adjusted for model 1 plus NT-proBNP levels, eGFR, and medications (including ACEIs/ARBs, beta-blockers)
  2. Abbreviations: 2OG 2-Oxoglutarate, BMI body mass index, LDL-C low-density lipoprotein cholesterol, AF Atrial fibrillation, DM Diabetes mellitus, NT-proBNP N-terminal pro B-type natriuretic peptide, eGFR estimated glomerular filtration rate, ACEIs/ARBs angiotensin-converting enzyme inhibitors/angiotensin receptor blockers